ESCRS - Supplement: Premium IOL Solutions - Your way out of the Labyrinth ;
ESCRS - Supplement: Premium IOL Solutions - Your way out of the Labyrinth ;
Supplements

Supplement: Premium IOL Solutions - Your way out of the Labyrinth

Supplement: Premium IOL Solutions - Your way out of the Labyrinth

One-stop premium IOL provider

In today's premium intraocular lens (IOL) market, the abundance of lens options and surgical techniques is overwhelming, evoking a sense of navigating through a labyrinth. A new paradigm has emerged: the art of selecting the right lens to match each patient's unique visual needs and expectations.

Medicontur has become a one-stop premium IOL provider for leading clinics around the world. This supplement showcases Medicontur's premium lead technologies and clinical insights by leading experts in the field of refractive surgery, showing a way out of this labyrinth.

Latest Articles
Glaucoma Treatment Under Pressure

New techniques and technologies add to surgeons’ difficult decisions

Read more...

Outside the Box, Inside the Pipeline

Researchers are tackling glaucoma diagnosis and treatment from all sides.

Read more...

The EHDS Is Ready for the Green Light

If proposal is approved, Europe could see better access to, and exchange and use of, health data.

Read more...

ESCRS to Release Guidelines for Cataract and Refractive Surgery

Comprehensive approach to the safest and most effective modern surgery.

Read more...

Barry Fellowship Opens Up ‘Whole New Field of Thought’

The 2022 recipient combines theoretical and practical to learn new treatments.

Read more...

Digitalising the OR—Experience and Perspectives

Benefits include saving time and improving outcomes.

Read more...

ESCRS Heritage Programme

Visionaries past and present.

Read more...

Dynamic Measures Needed for Quality of Vision

Functional visual acuity testing and straylight metering may better reflect real-world conditions.

Read more...

What Is Stopping Digital OR Adoption?

Ophthalmologists know the benefits—now it’s time to construct the right plan.

Read more...

Time to Move Beyond Monofocal IOLs?

European surgeons appear hesitant to first offer other presbyopia-correcting options to patients.

Read more...

;